Intrinsic Value of S&P & Nasdaq Contact Us

TRICCAR, Inc. TCCR OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
15/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

TRICCAR, Inc. (TCCR) generated $-39.65K in operating cash flow for fiscal year 2021. After capital expenditures of $0.00, free cash flow was $-39.65K.

Free cash flow margin was -40.3% of revenue. Cash conversion ratio was 0.44x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (15/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 0.44x suggests some earnings are non-cash items

Overall SharesGrow Score: 14/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
15/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
15/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
TRICCAR, Inc. Cash Flow History
Metric TTM FY2021 FY2020 FY2019 FY2018
Operating Cash Flow $-770.69K$-39.65K$-29.84K$-27.02K$-10.66K
Capital Expenditure $0.00$0.00$0.00$0.00$0.00
Free Cash Flow $-770.69K$-39.65K$-29.84K$-27.02K$-10.66K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message